A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
Clinical trial NCT00411034 · COMPLETED
Trial details
- NCT number
- NCT00411034
- Sponsor
- Alza Corporation, DE, USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.